根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$IsoRay(ISR)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-09-09 AccNo: 0001144204-16-123313 Size: 7 MB 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2016-09-08 AccNo: 0001144204-16-123262 Size: 146 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2016-07-08 AccNo: 0001144204-16-112285 Size: 15 KBItem 8.01: Other Events 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2016-06-24 AccNo: 0001144204-16-109620 Size: 198 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial Statem...
$IsoRay(ISR)$ 8-K - Current report Filed: 2016-06-13 AccNo: 0001144204-16-107935 Size: 31 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of Mat...
$ISORAY INC(ISR)$ SD - Filed: 2016-05-31 AccNo: 0001144204-16-105902 Size: 17 KB 网页链接
$ISORAY INC(ISR)$ 8-K - Current report Filed: 2016-05-10 AccNo: 0001144204-16-100478 Size: 86 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$ISORAY INC(ISR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-10 AccNo: 0001144204-16-100413 Size: 3 MB 网页链接
$ISORAY INC(ISR)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-29 AccNo: 0001144204-16-097787 Size: 411 KB 网页链接
$ISORAY INC(ISR)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-29 AccNo: 0001144204-16-097781 Size: 1 MB 网页链接